We are live on ! Find out more
HA

HHLR Advisors Portfolio holdings

AUM $1.67B
1-Year Est. Return 7.53%
This Fund
S&P 500
This Quarter Est. Return
+37.21%
1 Year Est. Return
+7.53%
3 Year Est. Return
+82.23%
5 Year Est. Return
+55.28%
10 Year Est. Return
AUM
$12.6B
AUM Growth
-$623M
Cap. Flow
-$2.3B
Cap. Flow %
-18.28%
Top 10 Hldgs %
64.34%
Holding
108
New
19
Increased
9
Reduced
15
Closed
13

Top Buys

Rank Stock Value
1
DASH icon
DoorDash
DASH
+$137M
2
KOD icon
Kodiak Sciences
KOD
+$129M
3
YQ
17 Education & Technology Group
YQ
+$67.2M
4
ROOT icon
Root
ROOT
+$47.7M
5
SE icon
Sea Limited
SE
+$44.5M

Top Sells

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$1.19B
2
ZM icon
Zoom
ZM
+$905M
3
UBER icon
Uber
UBER
+$339M
4
JD icon
JD.com
JD
+$202M
5
ALGN icon
Align Technology
ALGN
+$95.7M

Sector Composition

Rank Sector Weight
1 Healthcare 31.81%
2 Consumer Discretionary 26.55%
3 Technology 18.53%
4 Communication Services 8.53%
5 Consumer Staples 4.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VIE
26
DELISTED
Viela Bio, Inc. Common Stock
VIE
$85.7M 0.68%
2,382,414
-95,217
-4% -$3.34M
GOSS icon
27
Gossamer Bio
GOSS
$96M
$71.8M 0.57%
7,420,974
NBP
28
NovaBridge Biosciences American Depositary Shares
NBP
$192M
$70.6M 0.56%
1,496,540
SE icon
29
Sea Limited
SE
$66B
$67.2M 0.53%
337,622
+250,000
+285% +$44.5M
ALGS icon
30
Aligos Therapeutics
ALGS
$26.1M
$59.9M 0.48%
+86,603
New +$42.2M
YQ
31
17 Education & Technology Group
YQ
$19.8M
$59.5M 0.47%
+232,170
New +$67.2M
GMAB icon
32
Genmab
GMAB
$17.6B
$57.1M 0.45%
1,403,288
-96,712
-6% -$3.62M
PRLD icon
33
Prelude Therapeutics
PRLD
$370M
$53.7M 0.43%
750,000
KNSA icon
34
Kiniksa Pharmaceuticals
KNSA
$6.25B
$51.6M 0.41%
2,920,023
MELI icon
35
Mercado Libre
MELI
$95.2B
$46.1M 0.37%
27,525
TSM icon
36
TSMC
TSM
$2T
$43.7M 0.35%
400,495
AKRO
37
DELISTED
Akero Therapeutics
AKRO
$42.7M 0.34%
1,656,673
OTIS icon
38
Otis Worldwide
OTIS
$27.8B
$41.5M 0.33%
614,556
ROOT icon
39
Root
ROOT
$907M
$40.8M 0.32%
+144,444
New +$47.7M
AAPL icon
40
Apple
AAPL
$5.05T
$39.8M 0.32%
+300,000
New +$36.1M
KDP icon
41
Keurig Dr Pepper
KDP
$42.3B
$39.4M 0.31%
1,232,666
+748,598
+155% +$22.2M
Z icon
42
Zillow
Z
$7.91B
$39.2M 0.31%
302,336
FMTX
43
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
$38.4M 0.31%
1,100,000
+600,000
+120% +$26.1M
CALT
44
DELISTED
Calliditas Therapeutics AB American Depositary Shares
CALT
$35.6M 0.28%
1,047,687
+697,687
+199% +$21.2M
NKTX icon
45
Nkarta
NKTX
$154M
$34.1M 0.27%
555,556
AMG icon
46
Affiliated Managers Group
AMG
$9.75B
$34.1M 0.27%
335,073
YSG
47
Yatsen Holding
YSG
$319M
$34.1M 0.27%
+400,866
New +$33.5M
MLCO icon
48
Melco Resorts & Entertainment
MLCO
$2.22B
$31.5M 0.25%
1,698,877
OLMA icon
49
Olema Pharmaceuticals
OLMA
$991M
$29.8M 0.24%
+620,397
New +$29.1M
AXSM icon
50
Axsome Therapeutics
AXSM
$11.8B
$29.3M 0.23%
+360,000
New +$26.9M

Similar funds

HHLR Advisors's Q4 2020 Portfolio in Review

As of Q4 2020, HHLR Advisors held 108 positions worth $12.6B, down 4.7% from $13.2B the previous quarter. Its ten largest holdings account for 64% of the portfolio.

HHLR Advisors withdrew a net $2.3B in Q4 2020, closing 13 positions and reducing 15 holdings. Its most notable exit was Alibaba, an estimated $1.19B position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, up from 26% a quarter earlier, followed by Consumer Discretionary and Technology.

Against the trend, HHLR Advisors opened a new position in DoorDash worth $123M.

  • HHLR Advisors's largest Q4 2020 buy was DoorDash: 858,500 shares worth $123M.
  • HHLR Advisors added most to Sea Limited in Q4 2020, an estimated $44.5M increase.
  • HHLR Advisors's biggest Q4 2020 reduction was Zoom, cutting an estimated $905M.
  • HHLR Advisors fully exited Alibaba in Q4 2020, selling an estimated $1.19B.
  • HHLR Advisors's ten largest holdings make up 64% of its $12.6B portfolio in Q4 2020.
  • HHLR Advisors opened 19 new positions and closed 13 in Q4 2020.
  • HHLR Advisors's portfolio value fell 4.7% quarter-over-quarter to $12.6B.

Based on HHLR Advisors's 13F filing for Q4 2020, filed 12 Feb 2021.